Income Statement StemRIM

Stocks

4599

JP3399690001

Pharmaceuticals

Market Closed - Japan Exchange 12:00:00 04/09/2026 pm IST			5-day change	1st Jan Change
312.00 ^JPY	-0.64%		-12.61%	+18.63%

22/07	Stemrim Announces Patent Registration in Mexico for Redasemtide as Therapeutic Agent for Cartilage Disorders	CI
08/07	StemRIM Inc. Announces Patent Registration For Stem Cell Gene Therapy Technology SR-GT1 Aimed At Curative Treatment Of Dystrophic Epidermolysis Bullosa In South Korea	CI

3970f525e25a474a8e78d2e1af252b86.HxWK3ZtH2nsZNOP1AgxKaIeY3I5R2nle9PKu0IV4ncY.bSznk9oRu09XYISTWF4APfHwk7k-nzoOvaHqhd8VyqgmYcC0rjHvISxOtg

Published financial data: STEMRIM

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: July	2021 (JPY)	2022 (JPY)	2023 (JPY)	2024 (JPY)	2025 (JPY)
Revenues	140Cr	2.2Cr	235Cr	-	-
Total Revenues	140Cr	2.2Cr	235Cr	-	-
Gross Profit	140Cr	2.2Cr	235Cr	-	-
Selling General & Admin Expenses, Total	44Cr	55Cr	61Cr	60Cr	55Cr
R&D Expenses	152.3Cr	142.1Cr	156.7Cr	145.3Cr	139.4Cr
Depreciation & Amortization - (IS)	3.3Cr	3.3Cr	3.1Cr	2.8Cr	2.9Cr
Other Operating Expenses, Total	199.3Cr	200.3Cr	220.7Cr	207.6Cr	197.1Cr
Operating Income	-59Cr	-198.1Cr	14Cr	-207.6Cr	-197.1Cr
Other Non Operating Income (Expenses)	1Cr	90L	20L	-20L	10L
EBT, Excl. Unusual Items	-58Cr	-197.2Cr	14Cr	-207.8Cr	-197Cr
Other Unusual Items	70L	2.6Cr	2.4Cr	5.9Cr	4.2Cr
EBT, Incl. Unusual Items	-58Cr	-194.6Cr	17Cr	-201.9Cr	-192.8Cr
Income Tax Expense	60L	20L	10L	30L	10L
Earnings From Continuing Operations	-58Cr	-194.8Cr	17Cr	-202.2Cr	-192.9Cr
Net Income to Company	-58Cr	-194.8Cr	17Cr	-202.2Cr	-192.9Cr
Net Income - (IS)	-58Cr	-194.8Cr	17Cr	-202.2Cr	-192.9Cr
Net Income to Common Incl Extra Items	-58Cr	-194.8Cr	17Cr	-202.2Cr	-192.9Cr
Net Income to Common Excl. Extra Items	-58Cr	-194.8Cr	17Cr	-202.2Cr	-192.9Cr
Per Share Items
Net EPS - Basic	-10.02	-32.91	2.8	-32.98	-31.16
Basic EPS - Continuing Operations	-10.02	-32.91	2.8	-32.98	-31.16
Basic Weighted Average Shares Outstanding	5.81Cr	5.92Cr	6.01Cr	6.13Cr	6.19Cr
Net EPS - Diluted	-10.02	-32.91	2.69	-32.98	-31.16
Diluted EPS - Continuing Operations	-10.02	-32.91	2.69	-32.98	-31.16
Diluted Weighted Average Shares Outstanding	5.81Cr	5.92Cr	6.25Cr	6.13Cr	6.19Cr
Normalized Basic EPS	-6.27	-20.82	1.51	-21.18	-19.89
Normalized Diluted EPS	-6.27	-20.82	1.45	-21.18	-19.89
Supplemental Items
EBITDA	-55Cr	-193.2Cr	19Cr	-203.2Cr	-192.2Cr
EBITA	-59Cr	-198.1Cr	14Cr	-207.6Cr	-197.1Cr
EBIT	-59Cr	-198.1Cr	14Cr	-207.6Cr	-197.1Cr
Effective Tax Rate - (Ratio)	-1.04	-0.1	0.59	-0.15	-0.05
Normalized Net Income	-36Cr	-123.25Cr	9.06Cr	-129.88Cr	-123.12Cr
Supplemental Operating Expense Items
General and Administrative Expenses	6.3Cr	6.4Cr	6.4Cr	7.9Cr	6.6Cr
Research And Development Expense From Footnotes	152.3Cr	142.1Cr	156.7Cr	145.3Cr	139.4Cr

Fiscal Period: July	2021 (JPY)	2022 (JPY)	2023 (JPY)	2024 (JPY)	2025 (JPY)
Assets
Cash And Equivalents	1.02TCr	888Cr	1.02TCr	841Cr	699.4Cr
Total Cash And Short Term Investments	1.02TCr	888Cr	1.02TCr	841Cr	699.4Cr
Other Receivables	-	-	-	-	-
Total Receivables	-	-	-	-	-
Inventory	1.2Cr	40L	80L	2.9Cr	1.6Cr
Prepaid Expenses	27Cr	27Cr	21Cr	24Cr	20Cr
Other Current Assets, Total	4.4Cr	11Cr	80L	20Cr	12Cr
Total Current Assets	1.05TCr	926.2Cr	1.04TCr	887.7Cr	732.5Cr
Net Property Plant And Equipment	32Cr	27Cr	23Cr	18Cr	18Cr
Long-term Investments	8.7Cr	5.9Cr	3.8Cr	1.4Cr	1.1Cr
Other Intangibles, Total	10L	-	-	20L	20L
Other Long-Term Assets, Total	10L	20L	20L	20L	-
Total Assets	1.09TCr	959.7Cr	1.07TCr	908Cr	751.8Cr
Liabilities
Accounts Payable, Total	10L	-	-	-	10L
Accrued Expenses, Total	2.7Cr	2.9Cr	2.2Cr	2.4Cr	2.4Cr
Current Portion of Leases	30L	30L	-	-	-
Current Income Taxes Payable	5.2Cr	3.5Cr	6.9Cr	3.9Cr	3.1Cr
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	40L	40L	13Cr	40L	3.1Cr
Total Current Liabilities	8.7Cr	7.1Cr	22Cr	6.7Cr	8.7Cr
Long-Term Leases	30L	-	-	-	-
Deferred Tax Liability Non Current	1.3Cr	1.2Cr	1Cr	90L	70L
Other Non Current Liabilities	11Cr	11Cr	11Cr	11Cr	11Cr
Total Liabilities	21Cr	19Cr	34Cr	19Cr	20Cr
Common Stock, Total	3.2Cr	7.6Cr	1.5Cr	1Cr	1Cr
Additional Paid In Capital	1.05TCr	1.06TCr	901.1Cr	942.2Cr	963.4Cr
Retained Earnings	-23Cr	-218.2Cr	17Cr	-185.3Cr	-378.3Cr
Comprehensive Income and Other	40Cr	89Cr	117.5Cr	131.4Cr	145.2Cr
Total Common Equity	1.07TCr	940.4Cr	1.04TCr	889.3Cr	731.3Cr
Total Equity	1.07TCr	940.4Cr	1.04TCr	889.3Cr	731.3Cr
Total Liabilities And Equity	1.09TCr	959.7Cr	1.07TCr	908Cr	751.8Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	5.88Cr	5.94Cr	6.09Cr	6.15Cr	6.21Cr
ECS Total Common Shares Outstanding	5.88Cr	5.94Cr	-	6.15Cr	-
Book Value / Share	181.83	158.4	170.33	144.55	117.69
Tangible Book Value	1.07TCr	940.4Cr	1.04TCr	889.1Cr	731.1Cr
Tangible Book Value Per Share	181.81	158.4	170.33	144.52	117.66
Total Debt	60L	30L	0	0	0
Net Debt	-1.02TCr	-887.7Cr	-1.02TCr	-841Cr	-699.4Cr
Inventories - Raw Materials, Total	1.2Cr	40L	80L	2.9Cr	1.6Cr
Full Time Employees	46	44	45	44	45

Fiscal Period: July	2021 (JPY)	2022 (JPY)	2023 (JPY)	2024 (JPY)	2025 (JPY)
Net Income	-58Cr	-194.6Cr	17Cr	-201.8Cr	-192.7Cr
Depreciation & Amortization - CF	4.3Cr	4.9Cr	4.7Cr	4.4Cr	4.9Cr
Depreciation & Amortization, Total	4.3Cr	4.9Cr	4.7Cr	4.4Cr	4.9Cr
Other Operating Activities, Total	1.2Cr	60L	-10L	-40L	-20L
Change In Inventories	50L	70L	-40L	-2Cr	1.2Cr
Change In Accounts Payable	-26Cr	-1.5Cr	14Cr	-14Cr	-70L
Change in Other Net Operating Assets	25Cr	50Cr	78Cr	26Cr	46Cr
Cash from Operations	-52Cr	-140.4Cr	113.5Cr	-188.1Cr	-141.4Cr
Capital Expenditure	-8.9Cr	-	-	-20L	-4.3Cr
Sale (Purchase) of Intangible assets	-	-	-	-20L	-
Other Investing Activities, Total	-30L	-	-	-	10L
Cash from Investing	-9.2Cr	-	-	-40L	-4.2Cr
Issuance of Common Stock	11Cr	12Cr	20Cr	7.9Cr	4.1Cr
Other Financing Activities, Total	-30L	-30L	-30L	-10L	-
Cash from Financing	11Cr	11Cr	20Cr	7.8Cr	4.1Cr
Miscellaneous Cash Flow Adjustments	-10L	-	-	-	-
Net Change in Cash	-50Cr	-129.2Cr	133.7Cr	-180.7Cr	-141.5Cr
Supplemental Items
Cash Income Tax Paid (Refund)	30L	30L	30L	30L	30L
Levered Free Cash Flow	-72Cr	-126.21Cr	44Cr	-165.15Cr	-106.99Cr
Unlevered Free Cash Flow	-72Cr	-126.21Cr	44Cr	-165.15Cr	-106.99Cr
Change In Net Working Capital	30Cr	7.3Cr	-31Cr	39Cr	-16Cr

Fiscal Period: July	2021 (JPY)	2022 (JPY)	2023 (JPY)	2024 (JPY)	2025 (JPY)
Profitability
Return on Assets	-3.34	-12.08	0.88	-13.12	-14.84
Return on Total Capital	-3.44	-12.31	0.9	-13.47	-15.2
Return On Equity %	-5.4	-19.38	1.7	-20.99	-23.81
Return on Common Equity	-5.4	-19.38	1.7	-20.99	-23.81
Margin Analysis
Gross Profit Margin %	100	100	100	-	-
SG&A Margin	31.21	2.5T	25.91	-	-
EBITDA Margin %	-39.29	-8.78T	8.09	-	-
EBITA Margin %	-42.36	-9T	6.09	-	-
EBIT Margin %	-42.36	-9T	6.09	-	-
Income From Continuing Operations Margin %	-41.57	-8.85T	7.15	-	-
Net Income Margin %	-41.57	-8.85T	7.15	-	-
Net Avail. For Common Margin %	-41.57	-8.85T	7.15	-	-
Normalized Net Income Margin	-26.03	-5.6T	3.86	-	-
Levered Free Cash Flow Margin	-51.33	-5.74T	18.91	-	-
Unlevered Free Cash Flow Margin	-51.33	-5.74T	18.91	-	-
Asset Turnover
Asset Turnover	0.13	0	0.23	-	-
Fixed Assets Turnover	5.07	0.07	9.4	-	-
Short Term Liquidity
Current Ratio	120.66	130.45	48.11	132.49	84.2
Quick Ratio	116.92	125.07	47.08	125.52	80.39
Operating Cash Flow to Current Liabilities	-5.97	-19.77	5.23	-28.07	-16.25
Long Term Solvency
Total Debt/Equity	0.06	0.03	-	-	-
Total Debt / Total Capital	0.06	0.03	-	-	-
LT Debt/Equity	0.03	-	-	-	-
Long-Term Debt / Total Capital	0.03	-	-	-	-
Total Liabilities / Total Assets	1.95	2.01	3.15	2.06	2.73
Total Debt / EBITDA	-0.01	-0	-	-	-
Net Debt / EBITDA	18.48	4.59	-53.77	4.14	3.64
Total Debt / (EBITDA - Capex)	-0.01	-0	-	-	-
Net Debt / (EBITDA - Capex)	15.91	4.59	-53.77	4.13	3.56
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-33.33	-98.43	10.58T	-	-
Gross Profit, 1 Yr. Growth %	-33.33	-98.43	10.58T	-	-
EBITDA, 1 Yr. Growth %	-230.02	251.27	-109.83	-1.17T	-5.41
EBITA, 1 Yr. Growth %	-242.55	234.06	-107.22	-1.55T	-5.06
EBIT, 1 Yr. Growth %	-242.55	234.06	-107.22	-1.55T	-5.06
Earnings From Cont. Operations, 1 Yr. Growth %	-267.72	234.71	-108.62	-1.3T	-4.6
Net Income, 1 Yr. Growth %	-267.72	234.71	-108.62	-1.3T	-4.6
Normalized Net Income, 1 Yr. Growth %	-261.94	238.25	-107.35	-1.53T	-5.2
Diluted EPS Before Extra, 1 Yr. Growth %	-274.49	228.59	-108.17	-1.33T	-5.52
Inventory, 1 Yr. Growth %	-33.33	-66.67	100	262.5	-44.83
Net Property, Plant and Equip., 1 Yr. Growth %	41.05	-15.17	-17.52	-18.14	-2.7
Total Assets, 1 Yr. Growth %	-3.3	-12.03	11.56	-15.19	-17.2
Tangible Book Value, 1 Yr. Growth %	-1.41	-12.07	10.26	-14.25	-17.77
Common Equity, 1 Yr. Growth %	-1.41	-12.08	10.26	-14.23	-17.77
Cash From Operations, 1 Yr. Growth %	-190.26	170.52	-180.84	-265.73	-24.83
Capital Expenditures, 1 Yr. Growth %	-41.45	-	-	-	2.05T
Levered Free Cash Flow, 1 Yr. Growth %	-360.37	75.63	-135.21	-471.65	-35.22
Unlevered Free Cash Flow, 1 Yr. Growth %	-360.37	75.63	-135.21	-471.65	-35.22
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	274.17	-89.76	29.56	-	-
Gross Profit, 2 Yr. CAGR %	274.17	-89.76	29.56	-	-
EBITDA, 2 Yr. CAGR %	-12.9	113.71	-41.22	2.56	218.05
EBITA, 2 Yr. CAGR %	-9.62	118.22	-50.89	2.37	271.26
EBIT, 2 Yr. CAGR %	-9.62	118.22	-50.89	2.37	271.26
Earnings From Cont. Operations, 2 Yr. CAGR %	-10.16	136.94	-46.27	1.88	238.85
Net Income, 2 Yr. CAGR %	-10.16	136.94	-46.27	1.88	238.85
Normalized Net Income, 2 Yr. CAGR %	-10.14	134.05	-50.13	2.65	268.59
Diluted EPS Before Extra, 2 Yr. CAGR %	-22.89	139.45	-48.18	0.1	240.32
Inventory, 2 Yr. CAGR %	0	-52.86	-18.35	169.26	41.42
Net Property, Plant and Equip., 2 Yr. CAGR %	499.07	9.38	-16.35	-17.83	-10.76
Total Assets, 2 Yr. CAGR %	101.49	-7.77	-0.93	-2.73	-16.2
Tangible Book Value, 2 Yr. CAGR %	103.05	-6.89	-1.54	-2.77	-16.03
Common Equity, 2 Yr. CAGR %	103.02	-6.9	-1.54	-2.75	-16.02
Cash From Operations, 2 Yr. CAGR %	-18.27	56.26	47.88	15.75	11.62
Capital Expenditures, 2 Yr. CAGR %	321.9	-	-	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	16.25	113.84	-21.36	14.39	55.16
Unlevered Free Cash Flow, 2 Yr. CAGR %	16.25	113.84	-21.36	14.39	55.16
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	91.29	-39.63	3.82	-	-
Gross Profit, 3 Yr. CAGR %	91.29	-39.63	3.82	-	-
EBITDA, 3 Yr. CAGR %	-	38.64	-23.42	54.59	-0.17
EBITA, 3 Yr. CAGR %	16.5	39.74	-29.95	51.84	-0.17
EBIT, 3 Yr. CAGR %	16.5	39.74	-29.95	51.84	-0.17
Earnings From Cont. Operations, 3 Yr. CAGR %	21.69	39.28	-21.48	51.46	-0.33
Net Income, 3 Yr. CAGR %	21.69	39.28	-21.48	51.46	-0.33
Normalized Net Income, 3 Yr. CAGR %	21.26	39.78	-26.15	52.75	-0.03
Diluted EPS Before Extra, 3 Yr. CAGR %	5.82	25.01	-22.33	48.77	-1.81
Inventory, 3 Yr. CAGR %	6.27	-30.66	-23.69	34.2	58.74
Net Property, Plant and Equip., 3 Yr. CAGR %	277.59	212.25	-0.44	-16.95	-13.07
Total Assets, 3 Yr. CAGR %	78.32	52.86	-1.73	-5.93	-7.82
Tangible Book Value, 3 Yr. CAGR %	78.77	53.62	-1.49	-5.97	-8.05
Common Equity, 3 Yr. CAGR %	78.77	53.6	-1.5	-5.97	-8.04
Cash From Operations, 3 Yr. CAGR %	-	21.8	25.44	53.61	0.24
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-71.78	-
Levered Free Cash Flow, 3 Yr. CAGR %	-	33.39	17.21	31.96	-5.36
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	33.39	17.21	31.96	-5.36
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-40.7	63.68	-	-
Gross Profit, 5 Yr. CAGR %	-	-40.7	63.68	-	-
EBITDA, 5 Yr. CAGR %	-	-	-	22.89	35.36
EBITA, 5 Yr. CAGR %	-	65.41	-17.54	23.38	36.5
EBIT, 5 Yr. CAGR %	-	65.41	-17.54	23.38	36.5
Earnings From Cont. Operations, 5 Yr. CAGR %	-	73.75	-12.26	22.9	40.93
Net Income, 5 Yr. CAGR %	-	73.75	-12.26	22.9	40.93
Normalized Net Income, 5 Yr. CAGR %	-	66.31	-15.01	23.54	40.49
Diluted EPS Before Extra, 5 Yr. CAGR %	-	56.82	-20.46	14.38	40.26
Inventory, 5 Yr. CAGR %	-	-	-4.36	19.3	-2.33
Net Property, Plant and Equip., 5 Yr. CAGR %	-	108.22	106.63	83.06	-4.7
Total Assets, 5 Yr. CAGR %	-	55.87	40.96	27.57	-7.8
Tangible Book Value, 5 Yr. CAGR %	-	56.84	40.83	27.94	-7.59
Common Equity, 5 Yr. CAGR %	-	56.84	40.83	27.93	-7.59
Cash From Operations, 5 Yr. CAGR %	-	-	-	19.34	19.72
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-16.74	-22.32
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	25.44	31.12
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	25.44	31.12